APDDR-0901

cosmeceutical formulation (0.03% retinol, 0.7% rose extract, and 0.05% hexamidine diisethionate) for the treatment of mild-to-moderate acne vulgaris

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Kim, Jeong Hwan: 1 article (11/2011)
2.	Kim, Nack In: 1 article (11/2011)
3.	Kim, Young Hoon: 1 article (11/2011)
4.	Ko, Joo Yeon: 1 article (11/2011)
5.	Koh, Hyun Ju: 1 article (11/2011)
6.	Lee, Ha Eun: 1 article (11/2011)
7.	Moon, Sang Ho: 1 article (11/2011)
8.	Park, Chun Wook: 1 article (11/2011)
9.	Park, Won Seok: 1 article (11/2011)
10.	Ro, Young Suck: 1 article (11/2011)

Related Diseases

1.

Acne Vulgaris 11/01/2011 - "In conclusion, APDDR-0901 could be an effective and safe alternative in the treatment of mild-to-moderate acne." 11/01/2011 - "A double-blind randomized controlled comparison of APDDR-0901, a novel cosmeceutical formulation, and 0.1% adapalene gel in the treatment of mild-to-moderate acne vulgaris." 11/01/2011 - "In this study, we compared the efficacy and safety of the combination product APDDR-0901 (0.03% retinol, 0.7% rose extract, and 0.05% hexamidine diisethionate) vs 0.1% adapalene gel for the treatment of mild-to-moderate acne. "

Related Drugs and Biologics

1.	Vitamin A (Retinol)
2.	Adapalene (Differin)
3.	hexamidine
4.	Cosmeceuticals